Summary
Salwa Naushin, Ph.D., earned her bachelor's degree in microbiology and her master's in genetics from the University of Delhi. She then completed a Ph.D. in biological sciences at the CSIR-Institute of Genomics and Integrative Biology. The Ph.D. focused on identifying potential biomarkers for coronary artery disease in an Indian cohort using a comprehensive multiomics approach.
Dr. Naushin has actively contributed to cross-disciplinary projects, including leading a large-scale sero-epidemiological survey with over 10,000 participants during the COVID-19 pandemic. She has also collaborated on studies examining the Delta variant and the impact of vaccination. Dr. Naushin's past research involved exploring how a specific gene related to nerve cells is controlled, which she conducted at the National Institute of Immunology. She also studied anthocyanidin-induced DNA protection in mouse models at Jawaharlal Nehru University. Dr. Naushin joined the NIH as a postdoctoral fellow at NIAMS in 2024.
Research Statement
Dr. Naushin's research focuses on the molecular effects of glucocorticoids on cells in patients with systemic lupus erythematosus (SLE), a systemic autoimmune disease. Glucocorticoids play a crucial role in anti-inflammatory and immunosuppressive therapies. They are often used to treat patients with SLE, but the molecular mechanisms behind their therapeutic effects remain unclear.
Glucocorticoids are effective but have extensive and serious side effects affecting every organ system. Dr. Naushin's work towards a better understanding of the therapeutic effects of glucocorticoids in patients with SLE aims to help develop more effective and safer treatment regimens.
Scientific Publications
Education
CSIR-Institute of Genomics and Integrative biology,New Delhi,India
Ph.D., Biological Sciences (2016-2023)
University of Delhi
M.Sc., Genetics (2013-2015)
University of Delhi
B.Sc., Microbiology (2010-2013)
